BREAKING NEWS: Cogiscan to Introduce Factory Intelligence – Analytics at productronica
Valtronic Partners with Synapse Biomedical to Help Commercialize Fully Implantable Neurostimulation Technology
Thursday, November 19, 2015

Valtronic, contract manufacturer of miniaturized electronic products for trusted medical device partners, announces that it is partnering with Synapse Biomedical to commercialize a fully implantable version of the neurostimulation technology upon which Synapse Biomedical was founded.

The Oberlin-based company is in the process of licensing the third-generation diaphragm pacing technology from Case Western Reserve University, and is working with several international partners to make the project a success. This fully implantable version will feature leads that deliver electricity directly to the diaphragm, and no longer will protrude from the skin.

The project is being funded by a $3 million grant from the Ohio Third Frontier economic development program. Several of the partners — Including Valtronic — plan to provide matching funds. Synapse will commercialize the technology in Asia with the help of another partner, USCI Japan Ltd.

Synapse already sells the second-generation technology. The NeuRx Diaphragm Pacing System is best known for helping the late Superman actor Christopher Reeve breathe without a ventilator.

Before the company can sell the new technology, however, it will need to receive approval from regulators in the United States, Europe and Japan.

 

Skyscraper 1

Skyscraper 3